Opportunity Radar

← Back to search

Grant forecast

Collaborations to Enhance Drug Development and Regulatory Science

View on Grants.gov ↗ Sign in to save

Type
Grant forecast
Notice type
CA,G
Agency
Food and Drug Administration
Sub-agency
HHS-FDA
Solicitation #
FOR-FD-24-014
Posted
Nov 30, 2023
CFDA / Assistance listing
93.103
Award floor
$5,000,000
Award ceiling
$5,000,000
Contact
Terrin Brown Grantor · terrin.brown@fda.hhs.gov · (240) 402-7610
Source
Grants.gov

Description

This Notice of Funding Opportunity (NOFO) invites applications for a cooperative agreement to support, manage and facilitate Public-Private Partnerships and Collaborative activities as part of the Critical Path Initiative and to support regulatory science efforts. FDA and grantees will work together to develop innovative, collaborative projects in research, education, and outreach. These projects can help foster drug product innovation to 1) support efforts to accelerate drug product development; 2) support approaches to advanced manufacturing; 3) facilitate translation of basic science discoveries into therapeutics; and 4) facilitate approaches to enhance the safety, efficacy, quality, and performance of drug products. Projects are identified by FDA. Multiple awards may be funded under this NOFO and are directly dependent on drug development priorities and subject to the availability of funding.

Similar open opportunities